Insider · CIK 0001399546
Michael Truett Tate
cfoofficer
Files at ALAB (Astera Labs, Inc.). First filing Oct 11, 2024, latest Jun 3, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 8
$0 bought, $104M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALAB: Astera Labs, Inc.
ALABOct 9, 2026 · close 342.21
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | Astera Labs, Inc. | $45M 500,000 shares | -45% | +119% from low-38% from high | |
| 60Notable | Astera Labs, Inc. | $826k 9,107 shares | -4% | +119% from low-38% from high | |
| 82Strong | Astera Labs, Inc. | $10M 125,800 shares | -100% | +101% from low-43% from high | |
| 67Notable | Astera Labs, Inc. | $3.2M 34,474 shares | -12% | +126% from low-36% from high | |
| 42Moderate | Astera Labs, Inc. | $1.9M 16,000 shares | -1% | - | |
| 47Moderate | Astera Labs, Inc. | $36M 334,000 shares | -19% | - | |
| 57Moderate | Astera Labs, Inc. | $672k 7,398 shares | -3% | - | |
| 42Moderate | Astera Labs, Inc. | $6.2M 100,000 shares | -5% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -19,998 | $88.14 | $1.8M | 1,098,998 | Jun 3, 2025 |
| May 30, 2025 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -92,200 | $89.05 | $8.2M | 1,006,798 | Jun 3, 2025 |
| May 30, 2025 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -156,288 | $90.06 | $14M | 850,510 | Jun 3, 2025 |
| May 30, 2025 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -204,954 | $90.75 | $19M | 645,556 | Jun 3, 2025 |
| May 30, 2025 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -15,492 | $92.04 | $1.4M | 630,064 | Jun 3, 2025 |
| May 30, 2025 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -3,968 | $92.96 | $369k | 626,096 | Jun 3, 2025 |
| May 30, 2025 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -7,100 | $94.33 | $670k | 618,996 | Jun 3, 2025 |
| May 16, 2025 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stock | -881 | $92.16 | $81k | 243,361 | May 20, 2025 |
| May 16, 2025 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stock | -4,247 | $90.67 | $385k | 239,114 | May 20, 2025 |
| May 16, 2025 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stock | -3,979 | $90.33 | $359k | 235,135 | May 20, 2025 |
| Feb 26, 2025 | ALAB Astera Labs, Inc. | GGift Common Stockindirect: By Tate Trust | -125,800 | $0.00 | $0 | 1,244,796 | Feb 28, 2025 |
| Feb 26, 2025 | ALAB Astera Labs, Inc. | GGift Common Stockindirect: By CRUT Trust | +125,800 | $0.00 | $0 | 125,800 | Feb 28, 2025 |
| Feb 26, 2025 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By CRUT Trust | -125,800 | $82.53 | $10M | 0 | Feb 28, 2025 |
| Feb 27, 2025 | ALAB Astera Labs, Inc. | GGift Common Stockindirect: By Tate Trust | -125,800 | $0.00 | $0 | 1,118,996 | Feb 28, 2025 |
| Feb 18, 2025 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stock | -34,474 | $92.07 | $3.2M | 244,242 | Feb 20, 2025 |
| Dec 11, 2024 | ALAB Astera Labs, Inc. | GGift Common Stockindirect: By Tate Trust | -30,000 | $0.00 | $0 | 1,390,596 | Dec 13, 2024 |
| Dec 11, 2024 | ALAB Astera Labs, Inc. | GGift Common Stockindirect: By Tate Trust | -10,000 | $0.00 | $0 | 1,380,596 | Dec 13, 2024 |
| Dec 11, 2024 | ALAB Astera Labs, Inc. | GGift Common Stockindirect: By Tate Trust | -10,000 | $0.00 | $0 | 1,370,596 | Dec 13, 2024 |
| Dec 4, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -3,622 | $115.44 | $418k | 1,425,266 | Dec 6, 2024 |
| Dec 4, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -1,900 | $116.66 | $222k | 1,423,366 | Dec 6, 2024 |
| Dec 4, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -2,840 | $117.68 | $334k | 1,420,526 | Dec 6, 2024 |
| Dec 4, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -2,602 | $118.44 | $308k | 1,417,924 | Dec 6, 2024 |
| Dec 4, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -4,353 | $119.67 | $521k | 1,413,571 | Dec 6, 2024 |
| Dec 4, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -683 | $120.58 | $82k | 1,412,888 | Dec 6, 2024 |
| Dec 2, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -24,077 | $101.62 | $2.4M | 1,738,811 | Dec 4, 2024 |
| Dec 2, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -55,003 | $102.59 | $5.6M | 1,683,808 | Dec 4, 2024 |
| Dec 2, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -84,220 | $103.49 | $8.7M | 1,599,588 | Dec 4, 2024 |
| Dec 2, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -3,700 | $104.44 | $386k | 1,595,888 | Dec 4, 2024 |
| Dec 3, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -1,185 | $105.80 | $125k | 1,594,703 | Dec 4, 2024 |
| Dec 3, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -1,600 | $107.08 | $171k | 1,593,103 | Dec 4, 2024 |
| Dec 3, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -1,180 | $108.16 | $128k | 1,591,923 | Dec 4, 2024 |
| Dec 3, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -4,575 | $109.58 | $501k | 1,587,348 | Dec 4, 2024 |
| Dec 3, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -21,670 | $110.52 | $2.4M | 1,565,678 | Dec 4, 2024 |
| Dec 3, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -19,793 | $111.32 | $2.2M | 1,545,885 | Dec 4, 2024 |
| Dec 3, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -27,905 | $112.53 | $3.1M | 1,517,980 | Dec 4, 2024 |
| Dec 3, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -18,489 | $113.54 | $2.1M | 1,499,491 | Dec 4, 2024 |
| Dec 3, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -19,804 | $114.54 | $2.3M | 1,479,687 | Dec 4, 2024 |
| Dec 3, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -25,978 | $115.71 | $3.0M | 1,453,709 | Dec 4, 2024 |
| Dec 3, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -23,222 | $116.46 | $2.7M | 1,430,487 | Dec 4, 2024 |
| Dec 3, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -1,599 | $117.10 | $187k | 1,428,888 | Dec 4, 2024 |
| Nov 18, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stock | -7,398 | $90.81 | $672k | 286,424 | Nov 20, 2024 |
| Nov 14, 2024 | ALAB Astera Labs, Inc. | AGrant or award Common Stock | +694 | $30.60 | $21k | 293,822 | Nov 18, 2024 |
| Oct 9, 2024 | ALAB Astera Labs, Inc. | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -100,000 | $62.03 | $6.2M | 1,762,888 | Oct 11, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.